Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 P482 | DOI: 10.1530/endoabs.110.P482

ECEESPE2025 Poster Presentations Endocrine Related Cancer (76 abstracts)

Ectopic adrenocorticotrophic hormone secreting bronchial carcinoid: a retrospective study from a tertiary center

Archana K 1 , Preeti Dabadghao 1 , Subhash Yadav 1 & Bibhuti Mohanta 1


1Sanjay Gandhi Postgraduate Institute of Medical Sciences, Endocrinology, Lucknow, India


JOINT431

Introduction: Adrenocorticotropic hormone (ACTH)- producing extra-pituitary tumors are 8-18% of endogenous cushing’s syndrome, and their frequency is often underestimated. This low frequency poses a challenge to acquiring experience in their management.

Methods: A retrospective study was undertaken at a tertiary center in Lucknow. Cases were identified through the Hospital Information System from 2000 to 2024. A cohort of eleven cases of bronchial carcinoid-secreting ACTH was retrieved. The biochemical parameters, hormonal profile, localization studies, medical and surgical treatment, and outcomes were analyzed. Data are presented as median with inter-quartile range (IQR) and percentage.

Results: Out of 11 patients, men constituted 70%. The median age of presentation was 28 years (IQR-26-43). Clinically all patients had cushingoid features and hyperpigmentation, hypokalaemia(63. 6%), hypertension(63. 6%), diabetes(72. 7%), fractures(9%), low bone mass(54. 5%) of patients. The median values of endocrine investigations are mentioned in Table 1. Localization study- Inferior petrosal sinus sampling median ratio of central to periphery was 0. 96 (IQR-0. 85-1. 08). Computed tomography and DOTANOC scan had localized lesions to right lung (54. 5%) and left lung(45. 5%). Ketoconazole usage prior to surgery in 54. 5%. Surgical excision through thoracotomy in all patients. Re-surgery was required in 27. 3%. Bilateral adrenalectomy was done in 18. 2%. Remission achieved in 81. 8% in a median duration of 28 months(IQR 3-75)(1 is lost to follow-up). No patient received antitumor treatment.

Table 1: Endocrine Investigations
Patient No8am cortisol (nmol/l)11pm cortisol (nmol/l)ACTH (pmol/l)LNSC (nmol/l)Urinary free cortisol (mg/dl)ONDST (nmol/l)LDDST (nmol/l)HDDST (nmol/l)
1892-147. 5-1234512-720
2618104396. 7-2475618789894
3817-40-120516555-
470494120. 7-2012701-107
51173100754. 4-1554-927773
67486932952. 8-621-528
7107388027. 970-512588249
81288120243106-1161562
99385784064-657524755
10826719196. 454-985886952
Median88688040591554619. 5688. 5641
IQR 174870627. 945. 85677513531. 75292. 5
IQR 31073102596. 7792243. 5690916. 75803. 25

Conclusion: Ectopic cushing’s syndrome is an uncommon clinical syndrome that is associated with significant morbidity and mortality. Antitumor treatment and control of hypercortisolism is equally important and therefore a multidisciplinary approach.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches